GGM Financials »

Regeneron Pharmaceuticals shares owned by GGM Financials

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by GGM Financials from 13F filings

Historical chart of GGM Financials investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by GGM Financials consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by GGM Financials

Quarter filed Position value Share count Share price at filing
2024-09-30 $278k 264 1051.24
2024-06-30 $278k 264 1051.03

More positions owned by GGM Financials

Invesco Exchange Traded Fd T S&p Mdcp Quality (XMHQ)
Putnam Etf Trust Focused Lar Cap (PVAL)
Goldman Sachs Etf Tr Nasdaq 100 Core (GPIQ)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Ishares Tr 10-20 Yr Trs Etf (TLH)
J P Morgan Exchange Traded F Active Growth (JGRO)
J P Morgan Exchange Traded F Active Value Etf (JAVA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Usa Min Vol (USMV)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Apple (AAPL)
Procter & Gamble Company (PG)
Abbvie (ABBV)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)

View all positions for GGM Financials

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Dodge & Cox
Geode Capital Management
Franklin Resources
Morgan Stanley
T. Rowe Price Associates
Invesco
Bank of America Corporation
Amundi

View all funds holding Regeneron Pharmaceuticals